Adenosine deaminase inhibitors: Their role in chemotherapy and immunosuppression
- 1 November 1980
- journal article
- review article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 4 (4) , 227-235
- https://doi.org/10.1007/bf00255266
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Metabolic formation of nucleoside-modified analogues of S-adenosylmethionineBiochemical and Biophysical Research Communications, 1979
- Adenylate deaminase: Potent inhibition by 2′-deoxycoformycin 5′-phosphateBiochemical and Biophysical Research Communications, 1979
- Adenosine deaminase inhibitors: Differential effects on multiple forms of adenosine deaminaseBiochemical and Biophysical Research Communications, 1978
- Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency diseaseCell, 1978
- Cordycepin and xylosyladenine: Inhibitors of methylation of nuclear RNABiochemical and Biophysical Research Communications, 1978
- Role of S-adenosylhomocysteine in adenosine-mediated toxicity in cultured mouse T lymphoma cellsCell, 1977
- INHIBITION OF ADENOSINE DEAMINASE BY CO-VIDARABINE AND ITS EFFECT ON THE METABOLIC DISPOSITION OF ADENINE ARABINOSIDE (VIDARABINE)Annals of the New York Academy of Sciences, 1977
- Inhibition for ImmunosuppressionNew England Journal of Medicine, 1977
- Adenosine Inhibition of Lymphocyte-Mediated Cytolysis: Possible Role of Cyclic Adenosine MonophosphateScience, 1975
- Molecular form of adenosine deaminase in severe combined immunodeficiencyBiochemical and Biophysical Research Communications, 1974